Ipamorelin is widely considered the gold standard among growth hormone secretagogue peptides. Its combination of selectivity, tolerability, and clean GH stimulation makes it the most recommended GH peptide in clinical practice. This guide covers everything you need to know about how it works, what it does, and how Longegra uses it.
What Is Ipamorelin?
Ipamorelin is a synthetic pentapeptide (five amino acid sequence) that acts as a selective agonist of the ghrelin receptor (also known as the growth hormone secretagogue receptor, or GHSR). By binding to GHSR in the pituitary gland and hypothalamus, it stimulates the release of growth hormone in a pulsatile pattern that closely mirrors the body's natural GH secretion.
The word "selective" is key here. Ipamorelin is designed to stimulate GH release with minimal effect on cortisol, prolactin, or other hormones. This selectivity is what distinguishes it from earlier GHRPs (GHRP-6, GHRP-2) that also elevated cortisol and produced other off-target hormonal effects.
The Discovery of Ipamorelin's Selectivity
Early growth hormone secretagogue peptides (GHRP-6 and GHRP-2) were effective at raising GH but also elevated cortisol and prolactin to degrees that limited their clinical utility. Ipamorelin was specifically developed to retain GH-stimulating activity while eliminating these off-target effects.
Published studies confirmed that at doses producing equivalent GH release, ipamorelin produced no significant cortisol or prolactin elevation, making it the cleanest GH secretagogue in the GHRP family.
Key Benefits of Ipamorelin
Growth Hormone and IGF-1 Elevation
Ipamorelin produces significant GH pulses in the hours following injection, which drives IGF-1 production from the liver. IGF-1 is the primary mediator of most of GH's anabolic and metabolic effects.
Muscle Preservation and Growth
IGF-1 stimulates satellite cell activation (muscle stem cells), fibroblast proliferation, and protein synthesis in skeletal muscle. For athletes and individuals focused on body recomposition, this creates a more favourable anabolic environment.
Fat Oxidation
GH and IGF-1 promote fat oxidation, particularly mobilisation of visceral fat for use as fuel. Over months of consistent use, ipamorelin contributes meaningfully to body fat reduction alongside appropriate nutrition.
Sleep Quality and Architecture
Ipamorelin-stimulated GH release aligns naturally with sleep-associated GH pulsatility. Night-time ipamorelin injection enhances slow-wave sleep depth and duration, producing the improved recovery and energy that many patients notice first.
Tissue Repair and Recovery
IGF-1 accelerates tissue repair at multiple sites: muscle, tendon, ligament, and bone. Athletes using ipamorelin typically notice significantly improved recovery from training sessions and faster return to full function from minor injuries.
Anti-Aging Benefits
Declining GH and IGF-1 are among the primary hormonal drivers of age-related body composition changes, skin thinning, reduced bone density, and cognitive decline. Maintaining physiological IGF-1 levels through ipamorelin supports multiple longevity-relevant biological functions.
The Ipamorelin + CJC-1295 Stack
Ipamorelin is frequently combined with CJC-1295 because the two peptides work through complementary mechanisms:
- CJC-1295 acts on GHRH receptors to sustain tonic GH elevation over multiple days
- Ipamorelin acts on ghrelin receptors to amplify the pulsatile GH amplitude
The combination produces greater and more sustained IGF-1 elevation than either peptide alone and is the standard protocol at Longegra for body recomposition, performance, and anti-aging goals.
Administration
Ipamorelin is administered as a subcutaneous injection, typically before sleep to align with the natural nocturnal GH pulse. The half-life is approximately two hours, so the GH pulse it stimulates is acute and aligned with the timing of injection.
For maximum sleep benefit, injection 30 to 60 minutes before bed is the standard recommendation.
Side Effects and Safety
Ipamorelin is one of the best-tolerated GH peptides available. Commonly reported mild effects:
- Mild water retention and joint discomfort in the first few weeks (GH-related, self-resolving)
- Mild transient flushing or warmth immediately after injection
- Occasional mild headache in the first days of use
Unlike GHRP-6, ipamorelin does not significantly stimulate appetite, which is an advantage for patients who are not in a deliberate bulking phase.
Frequently Asked Questions (FAQs)
Sleep quality improvements are often noticed within two to four weeks. Body composition changes are measurable at three months. Significant IGF-1 elevation is confirmed by blood test at three months.
